Nektar Therapeutics (ITH0) Cash flow

1 Followers

Nektar Therapeutics Cash Flow

DE:ITH0's free cash flow for Q2 2026 was $-75.88M. For the 2026 fiscal year, DE:ITH0's free cash flow was decreased by $-31.50M and operating cash flow was $-75.77M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ -208.51M	$ -175.71M	$ -192.61M	$ -304.01M	$ -412.66M
Investing Cash Flow	$ -1.20M	$ 142.57M	$ 139.56M	$ 365.83M	$ 202.78M
Financing Cash Flow	$ 180.57M	$ 42.12M	$ 30.00K	$ 1.51M	$ 36.24M
End Cash Position	$ 15.12M	$ 44.25M	$ 35.28M	$ 88.23M	$ 25.22M
Free Cash Flow	$ -208.68M	$ -177.18M	$ -193.47M	$ -309.68M	$ -427.65M

Currency in USD